Figure 2

Forest plot showing the efficacy and safety outcomes between patients taking anticoagulants and those taking no anticoagulants in the prevention group. Note: VKA vitamin K antagonist, LMWH low-molecular-weight heparin, DOACs direct oral anticoagulants.